Site Members can sign up for company wide alerts
Lawsuit Overview
March 7, 2022 - An amended complaint was filed. June 8, 2021 - An investor in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between March 1...
You must register (for free) or login to view the entire case.